Dicerna Pharmaceutic
(DRNA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2014 | 12-2013 | 09-2013 | 06-2013 | 03-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 133,792 | 46,595 | 54,712 | N/A | N/A |
| TOTAL | $134,698 | $48,653 | $55,125 | $N/A | $N/A |
| Non-Current Assets | |||||
| PPE Net | 911 | 877 | 683 | N/A | N/A |
| Other Non-Current Assets | 264 | 264 | 264 | 0 | 0 |
| TOTAL | $1,175 | $1,141 | $947 | $N/A | $N/A |
| Total Assets | $135,873 | $49,794 | $56,072 | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 3,785 | 4,587 | 4,471 | N/A | N/A |
| Accounts payable and accrued liabilities | 715 | 1,700 | 1,557 | 0 | 0 |
| Accrued Expenses | 1,947 | 1,286 | 518 | N/A | N/A |
| TOTAL | $6,543 | $7,678 | $6,560 | $N/A | $N/A |
| Non-Current Liabilities | |||||
| Long Term Debt | 0 | 260 | 1,407 | N/A | N/A |
| Deferred Revenues | 96 | 105 | 14 | N/A | N/A |
| Other Non-Current Liabilities | 0 | 529 | 436 | 0 | 0 |
| TOTAL | $N/A | $789 | $1,843 | $N/A | $N/A |
| Total Liabilities | $6,543 | $8,467 | $8,403 | $N/A | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 17,763 | N/A | N/A | N/A | N/A |
| Common Shares | 2 | 1 | 1 | N/A | N/A |
| Retained earnings | -96,267 | -85,465 | -78,746 | N/A | N/A |
| Other shareholders' equity | 0 | 110,246 | 110,237 | 0 | 0 |
| TOTAL | $129,330 | $41,327 | $47,669 | $N/A | $N/A |
| Total Liabilities And Equity | $135,873 | $49,794 | $56,072 | $0 | $0 |